Can Cui

Associate | San Francisco | (415) 268-7275
(415) 268-7275

中文 | English

Dr. Can Cui is a member of the firm’s Technology Transactions Group and one of the leading practitioners in biotech and life sciences recognized by Berkeley Center for Law & Technology. His practice focuses on China-related life sciences transactions, including cross-border technology licensing and acquisitions, collaboration and strategic partnerships, joint ventures, and other forms of investments.

Can has extensive experience representing both technology licensors and licensees in life sciences licensing transactions, both domestic and across the Pacific. In private equity and venture capital transactions, he has advised institutional and individual investors, established life sciences companies and startups on intellectual property (IP) and technology due diligence matters, and negotiated and drafted related investment documentation. Can also advises clients on the IP aspects of mergers and acquisitions.

Can is also a member of the firm’s IP Group. For more than thirteen years, Can has prepared and prosecuted numerous patent applications in the United States in the areas of biotechnology, chemistry, medical devices, pharmaceuticals, and Internet technologies. Prior to his arrival in the Bay Area, Can was resident in the firm’s Hong Kong office for four years, where he managed patent infringement and invalidation proceedings in China on behalf of the firm’s U.S. technology clients and gained extensive experience in IP dispute resolution in China. He is a frequent guest lecturer at top universities in the United States and in China on U.S. patent law, patent licensing, and IP protection in the biotech industry, and he established and taught Chinese IP law at The Chinese University of Hong Kong for three years as an adjunct faculty member.

Can has a strong research background in biological and biomedical sciences. He was the recipient of the Karnovsky Fellowship and the Fu Fellowship at Harvard University, where he obtained his Ph.D. in biological chemistry & molecular pharmacology. As a graduate student at Harvard, he conceived, established, and maintained a major long-term collaborative project among Harvard Medical School, the University of California, San Diego, and the Chinese Academy of Sciences. His groundbreaking identification of a viral microRNA was featured in the “Spotlight” section of Journal of Virology as an article of significant interest selected by the editors. Can was a Shuping Scholar and valedictorian at Peking University, where he received his B.Sc. in biotechnology, with high distinction honor for his research and senior thesis on anti-breast cancer immunotherapy.

In addition to his legal services to the life sciences industry, Can is also an active participant in a wide variety of pro bono matters.  He has been a frequent recipient of the firm’s Pro Bono Star award and California Lawyers Association’s Wiley W. Manuel Certificate for Pro Bono Legal Services in recent years.

Prior to joining Morrison & Foerster, Can worked in a top boutique IP law firm in the United States, and then in a prestigious IP group of an international law firm as a U.S. patent agent. Can received his J.D., magna cum laude, from New York University School of Law (“NYU Law”), where he was the senior articles editor and board member of NYU Journal of Law & Business. He is a member of The Order of the Coif and the recipient of NYU Law’s only convocation award in IP law, the Walter J. Derenberg Prize. Can has a continuing scholarly research interest in patent law, particularly subject matter patent eligibility, and also in information privacy law, and has published articles in both areas.

Show More


Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.